about
Neurodegeneration and microtubule dynamics: death by a thousand cutsModeling the complex pathology of Alzheimer's disease in DrosophilaFasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders.Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal lossIschemic preconditioning, retinal neuroprotection and histone deacetylase activities.Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Invited review: Drug development for tauopathies.Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels.Therapeutic Strategies for Restoring Tau Homeostasis.Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegenerationInhibition of peptide aggregation by means of enzymatic phosphorylation.Alzheimer's disease: from molecule to clinic.Can numerical modeling help understand the fate of tau protein in the axon terminal?Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro.Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer's disease.Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.Amyloidogenesis of Tau protein.Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease.Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
P2860
Q26781649-4C4B1389-D911-483A-A0E6-75143867C64CQ28082451-8FA5E197-04E5-48BD-8818-7C851DC488D8Q36444140-53CA99D9-05D9-4AA9-9CAC-64EA88D5B8D0Q36591506-04793CC4-0B74-4F10-89C4-C87A1448E553Q36971583-9D9BE1CE-BDD5-4DFD-BB76-15C960021398Q37220632-47FE84C5-6027-4432-95FA-4EAAAC003B94Q38263698-07D22C9A-3389-444A-BBA0-18EA3F21EC6DQ38869291-7954A35B-163A-40DF-A63C-518B682C9D0FQ39118898-FC18E2EA-0346-4151-85A5-B57DBF51A8ECQ41202092-C62241F4-9568-44B8-818E-D87DEABCF60BQ42330245-72245607-5009-4272-8033-6DA4FD4F06BBQ42347359-791C1160-6292-456B-B29B-669EB1BCDBEFQ44877131-2E956C7B-2246-4C87-8CEE-414CB5DD81DDQ47104779-9BAC676C-37DF-4ACA-B848-16A942E210DDQ47446093-F7B29554-EF20-429C-81D5-B0911487877AQ47607239-01105FCE-4830-43A4-8EF2-800F8D957175Q47715943-FE9483E2-803C-4D30-ADF1-C58BC7812865Q53397811-55F25931-3FA2-494A-9B7E-4BF2AFDA968EQ57816597-3E563CD5-4F37-4050-93A1-0B8C33112B1B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tau-induced neurodegeneration: mechanisms and targets.
@en
type
label
Tau-induced neurodegeneration: mechanisms and targets.
@en
prefLabel
Tau-induced neurodegeneration: mechanisms and targets.
@en
P2093
P2860
P1476
Tau-induced neurodegeneration: mechanisms and targets.
@en
P2093
Alejandra del C Alonso
Cindy Beharry
Kawsar Ibrahim
Leah S Cohen
Susan Briffa-Mirabella
P2860
P2888
P304
P356
10.1007/S12264-013-1414-Z
P577
2014-04-15T00:00:00Z